Article | May 3, 2017

Bioburden Sources You Might Have Missed

Source: Cytiva

By David Westman, Global Product Marketing Manager BioProcess Chromatography Resins, GE Healthcare

Bioburden Sources You Might Have Missed

A problem with traditional mAb manufacturing is that there are so many potential entry points for microbial contamination. There are, however, ways to shut the door on contamination.

A complex issue

Monoclonal antibody (mAb) manufacturing is complex. This leads to many potential entry points for microbial contamination. What can you do to minimize the risk to patients—and your reputation?

VIEW THE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of BioProcess Online? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: